Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Transepicardial Atrial Injection of Saline at the Time Open Chest Cardiac Surgery

NCT05634213 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05634213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Transepicardial Atrial Injection of Saline at the Time Open Chest Cardiac Surgery
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Phase 1
Overall status
Withdrawn
Start date
March 1, 2023
Completion date
April 1, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery